US-based Abbott Laboratories has obtained an approval from the US Food and Drug Administration (FDA) for its MitraClip device, designed to treat patients with significant symptomatic degenerative mitral regurgitation (MR) who are at ...
Tags: FDA Approval, Abbott
Abbott has presented clinical study data from a Endovascular Valve Edge-to-Edge REpair STudy (EVEREST II ) High Surgical Risk cohort of its MitraClip System for the treatment of mitral regurgitation (MR). The CE-marked catheter-based ...
Tags: clinical study, MitraClip System, medical